Kinnos is a New York-based company that aims to raise the standard of infectious disease decontamination. Our first product, Highlight, is a patent-pending additive for disinfectants that greatly improve visibility, coverage, and end-user compliance to protect healthcare workers and patients. Highlight is directly mixed into disinfectants at point-of-use and works by colorizing the disinfectant and modifying the liquid properties to:

  • visualize sprayed regions
  • ensure full coverage and adherence to surfaces
  • increase viscosity and prevent misting of harmful fumes

Highlight fades to clear over time to provide real-time visual feedback of when decontamination is complete and to prevent staining.

Type
Private
HQ
New York, US
Founded
2014
Size (employees)
3 (est)
Website
kinnos.us
Kinnos was founded in 2014 and is headquartered in New York, US
Report incorrect company information

Key People/Management at Kinnos

Jason Kang

Jason Kang

Ceo, Cofounder
Kevin Tyan

Kevin Tyan

Cto, Cofounder
Katherine Jin

Katherine Jin

Coo, Cofounder

Kinnos Office Locations

Kinnos has an office in New York
New York, US (HQ)
760 Parkside Ave
Show all (1)
Report incorrect company information

Kinnos Financials and Metrics

Summary Metrics

Founding Date

2014

Total Funding

$1.8 m

Latest funding size

$1 m

Time since last funding

a year ago

Investors

Kinnos's latest funding round in February 2017 was reported to be $1 m. In total, Kinnos has raised $1.8 m
Show all financial metrics
Report incorrect company information